Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Arcutis Biotherapeutics (ARQT) Debt Ratio: 2021-2025

Historic Debt Ratio for Arcutis Biotherapeutics (ARQT) over the last 4 years, with Sep 2025 value amounting to 0.29.

  • Arcutis Biotherapeutics' Debt Ratio fell 37.48% to 0.29 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.29, marking a year-over-year decrease of 37.48%. This contributed to the annual value of 0.31 for FY2024, which is 48.02% down from last year.
  • Arcutis Biotherapeutics' Debt Ratio amounted to 0.29 in Q3 2025, which was down 4.60% from 0.31 recorded in Q2 2025.
  • Over the past 5 years, Arcutis Biotherapeutics' Debt Ratio peaked at 0.69 during Q3 2023, and registered a low of 0.18 during Q4 2021.
  • Its 3-year average for Debt Ratio is 0.45, with a median of 0.46 in 2024.
  • Per our database at Business Quant, Arcutis Biotherapeutics' Debt Ratio spiked by 162.19% in 2023 and then slumped by 48.02% in 2024.
  • Arcutis Biotherapeutics' Debt Ratio (Quarterly) stood at 0.18 in 2021, then skyrocketed by 148.33% to 0.44 in 2022, then soared by 34.29% to 0.59 in 2023, then slumped by 48.02% to 0.31 in 2024, then slumped by 37.48% to 0.29 in 2025.
  • Its Debt Ratio was 0.29 in Q3 2025, compared to 0.31 in Q2 2025 and 0.31 in Q1 2025.